• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人尿促卵泡激素在多囊卵巢不孕妇女中的应用。

Use of human urinary follicle-stimulating hormone in infertile women with polycystic ovaries.

作者信息

Flamigni C, Venturoli S, Paradisi R, Fabbri R, Porcu E, Magrini O

出版信息

J Reprod Med. 1985 Mar;30(3):184-8.

PMID:3923189
Abstract

Human urinary FSH (HU-FSH) was administered during 25 treatment cycles to 21 infertile women with polycystic ovary syndrome (PCO) who had failed to conceive in response to clomiphene citrate. HCG was also given in 23 of the cycles. Twenty-two (88%) ovulations occurred, and eight (38.1%) conceptions resulted, two (25%) of which terminated in abortion and six (75.0%) in normal deliveries. No multiple pregnancies occurred. Ten instances (40%) of mild-moderate hyperstimulation also resulted. A spontaneous LH surge was observed in 12 treatment cycles. Ultrasound scanning revealed multiple ovarian follicles developing at various rates. We conclude that HU-FSH is an effective form of treatment for women with PCO. However, the response to exogenous FSH is unpredictable and depends on the stage of development and the number of follicles present prior to stimulation.

摘要

在25个治疗周期中,对21名患有多囊卵巢综合征(PCO)且对枸橼酸氯米芬无反应而未能受孕的不孕妇女给予人尿促卵泡素(HU-FSH)。在23个周期中还给予了人绒毛膜促性腺激素(HCG)。发生了22次(88%)排卵,8次(38.1%)受孕,其中2次(25%)以流产告终,6次(75.0%)为正常分娩。未发生多胎妊娠。还出现了10例(40%)轻-中度卵巢过度刺激综合征。在12个治疗周期中观察到自发的促黄体生成素高峰。超声扫描显示多个卵巢卵泡以不同速率发育。我们得出结论,HU-FSH是治疗PCO女性的一种有效治疗方式。然而,对外源性促卵泡素的反应是不可预测的,并且取决于刺激前卵泡的发育阶段和数量。

相似文献

1
Use of human urinary follicle-stimulating hormone in infertile women with polycystic ovaries.人尿促卵泡激素在多囊卵巢不孕妇女中的应用。
J Reprod Med. 1985 Mar;30(3):184-8.
2
Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Int J Fertil. 1987 Jan-Feb;32(1):66-70.
3
Ovulation induction with gonadotropins in women with polycystic ovary disease.
J Reprod Med. 1991 Jan;36(1):61-4.
4
Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.用尿促卵泡素(美诺孕)诱导多囊卵巢疾病女性排卵及妊娠:临床经验总结
Acta Eur Fertil. 1983 Jan-Feb;14(1):29-34.
5
[Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):251-3.
6
Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.在世界卫生组织II组无排卵女性中起始剂量为50国际单位重组促卵泡激素的促排卵治疗:IO-50研究,一项前瞻性、观察性、多中心、开放性试验
BJOG. 2003 Dec;110(12):1072-7.
7
Ovulatory disorders in women with polycystic ovary syndrome.多囊卵巢综合征女性的排卵障碍
Clin Obstet Gynaecol. 1985 Sep;12(3):605-32.
8
The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.生长抑素类似物奥曲肽对多囊卵巢女性排卵功能的影响。
Hum Reprod. 1995 Jan;10(1):28-32. doi: 10.1093/humrep/10.1.28.
9
[Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].[在治疗棘手的无排卵性不育症中,就其促卵泡生成素含量而言的纯化人绝经期促性腺激素的作用]
J Gynecol Obstet Biol Reprod (Paris). 1987;16(5):621-6.
10
The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
Fertil Steril. 1980 May;33(5):479-86. doi: 10.1016/s0015-0282(16)44711-4.